Top Companies in Ablation Technology Market

The global ablation technology market is projected to reach USD 9.62 billion by 2029 from USD 6.11 billion in 2024, at a CAGR of 9.5% from 2024 to 2029. The ablation technology market is experiencing steady growth driven by increasing demand for minimally Invasive surgeries, rapidly aging populations across globe burdened with higher risk of targeted diseases and favorable reimbursement scenarios across developed markets

The market for ablation technology is growing strongly due to innovation in radiofrequency ablation. These technologies provide minimally invasive treatments for multiple medical conditions, such as cardiovascular diseases and cancer. Healthcare providers are incorporating these technologies for enhancing precision and efficacy, hence the growing demand for ablation devices.

To know about the assumptions considered for the study download the pdf brochure

Another significant driver is the emergence of pulsed-field ablation as an effective technology which employs high-voltage electrical pulses to create microscopic pores in cell membranes, inducing selective cell death. As technology advances in ablation device technology, in conjunction with real-time imaging, and increase in research and development expenditure, pulsed filed ablation is poised to be the source of momentum in the future of non-invasive treatment. As usage grows, it will further propel the growth of the market, facilitating enhanced treatment options.

The ablation technology market is consolidated. As of 2023, the key players operating in the global ablation technology market are Johnson & Johnson (US), Medtronic (US), Boston Scientific Corporation (US), Abbott (US), Atricure, Inc. (US). The top players in this market have adopted key strategies such as product approvals, launches, acquisitions, and acquisitions during the study period. In 2023, Johnson & Johnson (US), Medtronic (US), Boston Scientific Corporation (US), Abbott (US) held a major share of the ablation technology market.

Johnson & Johnson (US)

Johnson & Johnson offers ablation products through its subsidiary Ethicon Inc. and Biosense Webster, Inc. The company manufactures and commercializes pulsed field ablation platform and multiple products including therapeutic catheters. In order to meet patient demands and broaden the Biosense Webster’s portfolio in this sector, the company acquired Laminar, Inc. (US). The company is dedicated to research & development to provide novel equipment that improve patient outcomes; in FY 2023, the company invested ~USD 15 billion in R&D. The company offers ablation systems through its surgery division. The company has 89 manufacturing facilities with a maximum of them in the US. The company offers its products globally through direct presence or through various distribution channels.

Medtronic Plc (US)

Medtronic is major player operating in ablation technology market. Medtronic Plc operates in more than 150 countries worldwide across North America, Europe, the Asia Pacific, the Middle East & Africa, and Latin America. It offers cardiac ablation solutions through its cardiac rhythm & heart failure business segment. The company offers ablation systems for gastrointestinal and endoscopy purpose under Medical Surgical Portfolio. The company offers tumor ablation systems through its neuromodulation division. The company focuses on organic growth through innovation and launch of new and advanced products. The company has a global presence and operates in more than 150 countries worldwide.

Boston Scientific Corporation (US)

Boston Scientific Corporation (US) is another major player operating in the ablation technology market market. To achieve organic growth through innovation and collaborations, Boston Scientific Corporation focuses on strategic efforts. The company also acquired Lumenis LTD (Israel) which is involved in developing laser systems. The company strengthened its electrophysiology portfolio by acquiring Farapulse, Inc. (US) and Relievant Medsystems, Inc. (US). The company offers different ablation systems, catheters, and electrodes through MedSurg and Cardiovascular business segments. The company has its presence all over the world with 15 manufacturing facilities, out of which eight are located in the US and Puerto Rico, three in Ireland, two in Costa Rica, one in Malaysia, one in Brazil. The company has distribution and technology centers all over the world with its main customer fulfillment centers in Massachusetts, Japan, Malaysia and Netherlands.

Abbott. (US)

Abbott offers ablation devices under electrophysiology subsegment along with the ablation catheters. Abbott Laboratories functions through 291 international and 100 domestic subsidiaries, such as Abbott GmbH & Co., KG (Germany), Abbott Medical Optics, Inc., and Abbott Cardiovascular, Inc. (US) among others. The company offers its products globally through direct presence or distribution channels. The company acquired with Cardiovascular systems Inc. (US) to add alternative solution to Abbott’s portfolio for treatment of vascular disease.

Related Reports:

Ablation Technology Market by Technology (RF, Pulse Field, Microwave, Laser, Electrical, Ultrasound, Cryo), Product (Generator, Electrode, Probe), Application (CV, Cancer, Pain, Ortho, Cosmetics), Enduser (Hospital, ASC) & Region Global Forecasts to 2029

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com